Oropharyngeal Leak Pressure Monitoring Using Baska Versus I-gel Laryngeal Mask Airway

Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03725540
Collaborator
(none)
80
1
36
2.2

Study Details

Study Description

Brief Summary

The use of supraglottic airway devices with a gastric emptying tube in gynecological laparoscopic surgeries is growing. In addition to their ease of placement, they have low airway morbidity along with sufficient airway pressure in the Trendelenburg position and so they have been determined as an alternative to the endotracheal tube.

Condition or Disease Intervention/Treatment Phase
  • Device: I-gel
  • Device: Baska_mask

Detailed Description

The Baska mask is a novel supraglottic airway device with a non-inflatable cuff, an oesophageal drainage inlet and side channels to facilitate the aspiration of gastric contents and an integrated bite-block. The Baska mask comes in four sizes, ranging from pediatric to adult. The device appeared relatively easy to insert, provided a high-quality seal with the glottic aperture and the incidence of throat discomfort appeared low.

The I-gel a single use with noninflatable cuff and drain tube is being used for airway management during anesthesia since last few years. The noninflatable cuff of I-gel is made of a soft gel-like medical grade thermoplastic elastomer. The device has a buccal cavity stabilizer, an integral bite block and an epiglottic rest with a protective ridge, which prevents down folding of epiglottis during insertion.

An oropharyngeal leak pressure or 'leak' test is commonly performed with the laryngeal mask airway to quantify the efficacy of the seal with the airway. This value is important since it indicates the feasibility of positive pressure ventilation and the degree of airway protection from supracuff soiling.

Gynecological laparoscopic surgeries are associated with a decrease in thoraco-pulmonary compliance due to pneumoperitoneum and the Trendelenburg position. Minute ventilation needs to be increased to compensate for this reduction in compliance in order to maintain end-tidal carbon dioxide during pneumoperitoneum. This increase in minute ventilation can lead to an increase in airway pressures in excess of 20 cmH2O.

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Oropharyngeal Leak Pressure Monitoring With Baska Versus I-gel Laryngeal Mask Airway During Laparoscopic Gynecologic Surgery
Actual Study Start Date :
Nov 1, 2018
Anticipated Primary Completion Date :
Nov 1, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
I-gel group

Patients will be anesthetized using an appropriate sized I-gel mask according to the manufacturer's recommendations after lubrication with a water-soluble lubricant.

Device: I-gel
Patients will be anesthetized using an appropriate sized I-gel mask according to the manufacturer's recommendations after lubrication with a water-soluble lubricant.
Other Names:
  • I-gel LMA
  • BASKA Group

    Patients will be anesthetized using BASKA mask after lubrication with a water-soluble lubricant.

    Device: Baska_mask
    Patients will be anesthetized using BASKA mask after lubrication with a water-soluble lubricant.
    Other Names:
  • The Baska_ LMA
  • Outcome Measures

    Primary Outcome Measures

    1. Leak airway pressure [Intra-operative; after device insertion up to its removal]

      cmH2O

    Secondary Outcome Measures

    1. Peak airway pressure [Intra-operative; after device insertion up to its removal]

      cmH2O

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • BMI< 30kg/m2.

    • ASA physical status: I-II.

    • Operation: gynecological laparoscopic surgery

    • under general anesthesia of an anticipated duration<1h.

    Exclusion Criteria:
    • Patient refusal.

    • History of cardiac disease, psychological disorders, respiratory diseases including asthma, renal or hepatic failure.

    • Patients who have a high risk of regurgitation or aspiration based on a history of gastroesophageal reflux, hiatus hernia, diabetes and gross obesity.

    • Neck pathology

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 woman health hospital , Assiut university Assiut Egypt 71515

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Principal Investigator: Hala Abdelghaffar, MD, Professor of anesthesia, faculty of medicine, Assiut university, Egypt.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Hala Saad Abdel-Ghaffar, Principal Investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT03725540
    Other Study ID Numbers:
    • 17300223
    First Posted:
    Oct 31, 2018
    Last Update Posted:
    Jan 13, 2021
    Last Verified:
    Jan 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hala Saad Abdel-Ghaffar, Principal Investigator, Assiut University

    Study Results

    No Results Posted as of Jan 13, 2021